CXCL5 and cancer: Mostly recruited following a CXCL5 gradient (whose human orthologues, CXCL1 and IL‐8, are expressed by cancer cells), these immunosuppressive cells could in turn promote EMT‐like changes in cancer cells, via multiple pathways comprising TGF, EGF, and HGF (Fig. 1).